Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04498481
What this trial is testing

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Who this might be right for
Breast Cancer
Pfizer 1
Large-scale testing (Phase 3)Study completedNCT00460265
What this trial is testing

Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent and/or Metastatic Head and Neck Cancer
Amgen 658
Not applicableNot Yet RecruitingNCT07785453
What this trial is testing

Serum CTGF in Chronic Plantar Fasciitis

Who this might be right for
Plantar Fasciitis
Kanuni Sultan Suleyman Training and Research Hospital 60
Not applicableStudy completedNCT04704245
What this trial is testing

Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines

Who this might be right for
Epidermal Growth FactorNd-yttrium Aluminum Garnet LaserHyperpigmentation+1 more
Hallym University Kangnam Sacred Heart Hospital 40
Not applicableUnknownNCT02606019
What this trial is testing

The Use of Biomarkers in Predicting Dengue Outcome

Who this might be right for
Dengue
Universiti Tunku Abdul Rahman 108
Large-scale testing (Phase 3)Active Not RecruitingNCT05502237
What this trial is testing

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Gilead Sciences 1,021
Not applicableStudy completedNCT01902511
What this trial is testing

A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.

Who this might be right for
Decompensated Cirrhosis
Institute of Liver and Biliary Sciences, India 60
Testing effectiveness (Phase 2)WithdrawnNCT00540332
What this trial is testing

Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Who this might be right for
Head and Neck Cancer
Swedish Orphan Biovitrum
Testing effectiveness (Phase 2)Study completedNCT02476019
What this trial is testing

A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients

Who this might be right for
Obesity
Ionis Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT02272998
What this trial is testing

Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

Who this might be right for
Malignant Neoplasm
Sameek Roychowdhury 22
Not applicableStudy completedNCT00004419
What this trial is testing

Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance

Who this might be right for
Insulin ResistanceHyperglycemia
Beth Israel Deaconess Medical Center 18
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06250777
What this trial is testing

Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer
Yonsei University 27
Not applicableStudy completedNCT00679692
What this trial is testing

Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease

Who this might be right for
HepatitisLiver CirrhosisHepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 210
Not applicableStudy completedNCT03676400
What this trial is testing

Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia

Who this might be right for
Androgenic Alopecia
Medipost Co Ltd. 84
Testing effectiveness (Phase 2)WithdrawnNCT00727038
What this trial is testing

Lucentis for New Onset Neovascular Glaucoma

Who this might be right for
GlaucomaNew Onset GlaucomaNeovascular Glaucoma+1 more
University of Illinois at Chicago
Not applicableUnknownNCT02656589
What this trial is testing

MicroRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 300
Not applicableNot Yet RecruitingNCT07484997
What this trial is testing

Evaluating The Use of CGF Made Plugs in Mandibular Extraction Sites of Lower Impacted 3rd Molars.

Who this might be right for
Impacted Lower Third MolarAlveolar Bone Regeneration Following OdontectomyPostoperative Pain Management in Oral Surgery+1 more
Cairo University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Not applicableStudy completedNCT01933152
What this trial is testing

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Bayer 137
Post-approval studies (Phase 4)Study completedNCT00779935
What this trial is testing

Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)

Who this might be right for
Spondylitis, Ankylosing
Merck Sharp & Dohme LLC 44
Next Page